ASHA BYRD: Open Payments
NPI 1568035756 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169 in 9 payments from 7 companies in 2025. Trend: 2023 $905 · 2024 $461 · 2025 $169
Food & beverage: $169
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
Products named: AREXVY, UZEDY, GARDASIL 9, TRELEGY ELLIPTA, Rybelsus, ROTATEQ, UBRELVY, Doc Band.
Industry payments across CA — which companies pay providers there.
